methazolamide (Compound)

Synonyms:methazolamide, 554-57-4, Methenamide, Neptazaneat, Neptazane, Naptazane, N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide, CHEBI:6822, L584601, Methazolamide, (Z)-, NSC-758426, Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-, Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-, MLS000028532, CHEMBL288100, DA43GW06P1, VVP808, W733B0S9SD, DTXSID1023281, VVP-808, N-(3-Methyl-5-Sulfamoyl-1,3,4-Thiadiazol-2(3h)-Ylidene)acetamide, N-[(2E)-3-Methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide, NCGC00016508-01, Metazolamide, CAS-554-57-4, SMR000058287, N-(3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene)acetamide, L-584601, Metazolamide [DCIT], Metazolamida, Methazolamidum, (NE)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide, Acetamide, N-(5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)-, (N(Z))-, Metazolamida [INN-Spanish], Methazolamidum [INN-Latin], 1164547-86-7, 2101958-72-7, HSDB 3269, SR-05000001844, EINECS 209-066-7, BRN 0232387, UNII-W733B0S9SD, 2-Acetylimino-3-methyl-.delta.(4)-1,3,4-thiadiazoline-5-sulfonamide, 5-Acetylimino-4-methyl-.delta.(2)-1,3,4-thiadiazoline-2-sulfonamide, N-(4-Methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)acetamide, N-(5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide #, Acetamide, N-(4-methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)-, (Z)-methazolamide, Neptazane (TN), Methazolamide,(S), Methazolamide [USP:INN:BAN:JAN], Methazolamide, MZA, Prestwick_1007, Methazolamide (MZA), NoName_433, Spectrum_001615, Opera_ID_717, CHEMBL19, MZA3, Prestwick0_000802, Prestwick1_000802, Prestwick2_000802, Prestwick3_000802, Spectrum2_001543, Spectrum3_001914, Spectrum4_000190, Spectrum5_001006, 2-Acetylimino-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide, 5-Acetylimino-4-methyl-delta(sup 2)-1,3,4-thiadiazoline-2-sulfonamide, METHAZOLAMIDE [MI], METHAZOLAMIDE [INN], METHAZOLAMIDE [JAN], N-(4-Methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)acetamide, cid_4100, METHAZOLAMIDE [HSDB], UNII-DA43GW06P1, Oprea1_161738, SCHEMBL24686, SCHEMBL24687, BSPBio_000663, BSPBio_003508, KBioGR_000739, KBioSS_002095, METHAZOLAMIDE [VANDF], 4-27-00-08221 (Beilstein Handbook Reference), MLS001146905, DivK1c_000582, METHAZOLAMIDE [MART.], SPECTRUM1503252, SPBio_001386, SPBio_002584, METHAZOLAMIDE [USP-RS], METHAZOLAMIDE [WHO-DD], BPBio1_000731, DTXCID503281, GTPL6828, Methazolamide (JAN/USP/INN), US10172837, Methazolamide, CHEMBL1335656, SCHEMBL13825893, BDBM10881, CHEBI:94513, HMS501N04, KBio1_000582, KBio2_002095, KBio2_004663, KBio2_007231, KBio3_003013, DTXSID50901331, Methazolamide, >=98% (HPLC), NINDS_000582, BDBM315269, HMS1570B05, HMS1922M19, HMS2093A05, HMS2097B05, HMS2234L03, HMS3259H05, HMS3372G12, HMS3652E21, HMS3714B05, HMS3747O09, Pharmakon1600-01503252, METHAZOLAMIDE [ORANGE BOOK], HY-B0553, Tox21_110464, BDBM50013792, CCG-39321, METHAZOLAMIDE [USP MONOGRAPH], MFCD00083416, NSC758426, AKOS015897587, AKOS024464790, AKOS026749792, CCG-266836, CL 8490, DB00703, KS-5328, NC00618, NSC 758426, SB17307, Acetamide, N-(4-methyl-2-sulfamoyl-delta(sup 2)-1,3,4-thiadiazolin-5-ylidene)-, IDI1_000582, N-[(2E)-5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide, NCGC00016508-03, NCGC00016508-04, NCGC00016508-18, NCGC00018188-01, NCGC00018188-02, NCGC00018188-03, NCGC00018188-04, NCGC00018188-05, NCGC00018188-06, NCGC00018188-07, NCGC00022950-03, NCGC00022950-04, NCGC00178022-01, NCGC00178022-02, AC-32472, AS-13272, SBI-0051804.P002, DB-052736, AB00490015, S4039, SW197085-3, EN300-51717, C07764, D00655, D81966, AB00052336_04, EN300-7412532, A830656, Methazolamide, VETRANAL(TM), analytical standard, Q1149099, SR-05000001844-1, SR-05000001844-2, SR-05000001844-3, BRD-K13356952-001-15-2, BRD-K71053238-001-03-6, BRD-K71053238-001-04-4, Q27276292, Z728800602, (E)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene, N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)ethanamide, (NZ)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide, Methazolamide, United States Pharmacopeia (USP) Reference Standard, (E)-N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2(3H)-ylidene)acetamide, [N(E)]-N-[5-(Aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]acetamide, Acetamide, N-[5-(aminosulfonyl)-3-methyl-1,3,4-thiadiazol-2(3H)-ylidene]-, [N(E)]-, N-(4-METHYL-2-SULFAMOYL-.DELTA.(SUP 2)-1,3,4-THIADIAZOLIN-5-YLIDENE)ACETAMIDE, N-[(2Z)-3-methyl-5-sulfamoyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide
Pubchem:PUBCHEM:4100
Id:a3da3939-b42b-53dc-a118-dc006a0fa550
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View methazolamide's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for methazolamide.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with methazolamide.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.